Bloomberg Markets with Carol Massar and Cory Johnson.

GUEST:
Tatiana Darie
Health Care Stocks Reporter
Bloomberg News
Discussing Vertex Pharmaceuticals Inc. surging on Wednesday as its experimental new drug combinations helped more cystic fibrosis patients breathe far better than doctors and investors expected, opening a path to improved treatment for almost all patients with the lung disorder.

<p>Bloomberg Markets with Carol Massar and Cory Johnson.

GUEST:
Tatiana Darie
Health Care Stocks Reporter
Bloomberg News
Discussing Vertex Pharmaceuticals Inc. surging on Wednesday as its experimental new drug combinations helped more cystic fibrosis patients breathe far better than doctors and investors expected, opening a path to improved treatment for almost all patients with the lung disorder.</p>

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology. You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

<p>Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology.&nbsp;You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET:&nbsp;<a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;</p>

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Bloomberg Markets: Vertex Jumps as Drug Cocktails Aid Patients

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/8339a974-807e-41e8-a658-ae2b00f04ad0/transcript